AdvertisementAdvertise with NZME.
Latest from Stock takes
AdvertisementAdvertise with NZME.

Stock Takes: How Sharesies investors responded to ‘Liberation Day ’ convulsions
Sharesies investors have opted to play safe during convulsions on world markets.

What’s next for NZ stocks after a poor first quarter? Stock Takes
New Zealand shares suffered a poor first quarter, driven by sickly corporate earnings.

Stock Takes: Has ethical investing lost its shine?
The change of Government in the United States has put ESG investing on the back foot.

Stock Takes: Air NZ banks on loyal fliers for revenue boost
Analysts upgrade airline's rating but are dubious about some of its revenue plans.

Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.

Stock Takes: Why a2 is out of favour, and a role reversal for Fonterra
Private equity is seen as a likely buyer for Fonterra's consumer business.

Stock Takes: F&P Healthcare rebounds, tech sector surges and what next for cannabis company?
F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.

Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?

Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.